Prellis Biologics

(Image: Getty/Михаил Руденко)

Prellis raises $10.5m to advance 3D tissue printing

By Vassia Barba

Prellis advances its goal of using 3D holographic printing to create organoids for research and development – recently closing a $10.5m investment round to further develop its technology, which accelerates drug screening, says CEO.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers